{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(7)"],"submitter":["Onasanya AA"],"pubmed_abstract":["<h4>Objective</h4>To evaluate inhaler sustainability in asthma and Chronic Obstructive Pulmomary Disease (COPD) by analysing how inhaler design typology, prescribing and usage patterns, disposal and recycling practices influence human health and environmental outcomes, using a People-Process-Product (PPP) framework to identify actionable opportunities for improvement.<h4>Design</h4>A systematic review was conducted in May 2024, with reporting structured around the PPP framework using narrative synthesis.<h4>Data sources</h4>MEDLINE, Scopus, Cochrane Library and relevant grey literature were searched for publications over the period from April 2014 to April 2024.<h4>Eligibility criteria</h4>Studies were included if published between 2014 and 2024, involved patients with asthma or COPD and h"],"journal":["BMJ open"],"pagination":["e098052"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12306229"],"repository":["biostudies-literature"],"pubmed_title":["Inhaler sustainability in asthma and COPD care: a systematic review."],"pmcid":["PMC12306229"],"pubmed_authors":["Onasanya AA","Haider Y","Peaston G","Ignatowicz A","Turner AM"],"additional_accession":[]},"is_claimable":false,"name":"Inhaler sustainability in asthma and COPD care: a systematic review.","description":"<h4>Objective</h4>To evaluate inhaler sustainability in asthma and Chronic Obstructive Pulmomary Disease (COPD) by analysing how inhaler design typology, prescribing and usage patterns, disposal and recycling practices influence human health and environmental outcomes, using a People-Process-Product (PPP) framework to identify actionable opportunities for improvement.<h4>Design</h4>A systematic review was conducted in May 2024, with reporting structured around the PPP framework using narrative synthesis.<h4>Data sources</h4>MEDLINE, Scopus, Cochrane Library and relevant grey literature were searched for publications over the period from April 2014 to April 2024.<h4>Eligibility criteria</h4>Studies were included if published between 2014 and 2024, involved patients with asthma or COPD and h","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jul","modification":"2026-06-03T02:30:26.024Z","creation":"2025-08-30T03:06:57.743Z"},"accession":"S-EPMC12306229","cross_references":{"pubmed":["40713041"],"doi":["10.1136/bmjopen-2024-098052"]}}